

A recent study published in Neuropsychopharmacology reveals that nicotine, commonly associated with smoking, might have unexpected cognitive and anti-inflammatory benefits for individuals living with HIV (PLWH). While smoking is widely known for its adverse health effects, the study suggests that nicotine could temporarily improve cognitive control and reduce neuroinflammation in HIV-positive individuals.
Advances in antiretroviral therapy (ART) have turned HIV into a manageable chronic condition. However, PLWH still face persistent challenges such as chronic brain inflammation and cognitive impairment, including difficulty focusing, memory lapses, and goal management. Interestingly, nicotine, the active compound in tobacco, has shown anti-inflammatory properties and the ability to enhance cognitive performance in both humans and animal models.
Nicotine Study:
In this study, researchers examined 59 participants, divided into four groups:
- HIV-negative non-smokers
- HIV-negative smokers
- HIV-positive non-smokers
- HIV-positive smokers
Participants underwent cognitive assessments using the 5-choice continuous performance test (5C-CPT) to measure accuracy and reaction time during visual tasks. Additionally, neuroinflammation was evaluated by analyzing translocator protein (TSPO) levels via brain scans.
The findings revealed that smoking significantly reduced brain inflammation and improved cognitive performance in PLWH smokers compared to their non-smoking counterparts. Specifically, smokers demonstrated better task accuracy and target detection rates, indicating enhanced cognitive control. However, smoking did not affect response inhibition, suggesting its benefits were limited to certain cognitive functions.
Interestingly, lower neuroinflammation levels correlated directly with improved cognitive performance, reinforcing the theory that reduced inflammation contributes to cognitive benefits in PLWH smokers.
Despite these findings, researchers caution against viewing smoking as a therapeutic option. The well-documented harms of smoking, including increased risks of cancer, cardiovascular disease, and respiratory issues, far outweigh any temporary cognitive benefits.
Instead, the study highlights nicotine’s potential as a therapeutic agent for managing HIV-related neuroinflammation and cognitive impairments. Future research could explore safer delivery methods for nicotine or related compounds, offering a targeted approach to improve cognitive health in PLWH without the health risks associated with smoking.
More Information: Brody, A. L., Mischel, A. K., Sanavi, A. Y., Wong, A., Bahn, J. H., Minassian, A., Morgan, E. E., Rana, B., Hoh, C. K., Vera, D. R., Kotta, K. K., Miranda, A. H., Pocuca, N., Walter, T. J., Guggino, N., Beverly-Aylwin, R., Meyer, J. H., Vasdev, N., & Young, J. W. (2025) Cigarette smoking is associated with reduced neuroinflammation and better cognitive control in people living with HIV. Neuropsychopharmacology. doi: 10.1038/s41386-024-02035-6. https://www.nature.com/articles/s41386-024-02035-6
more recommended stories
Women’s Health: 195 New Genetic Risks Revealed
In a groundbreaking study published in.
Cytomegalovirus Transmission – New Study Uncovers Key to Prevention
A groundbreaking study co-authored by Weill.
Top 10 Spring CME/CE Conferences in USA – 2025
Staying up to date with the.
Semen Quality as a Predictor of Long-Term Health
A landmark study published in Human.
HPV-Negative Head & Neck Cancer: Hope in Immunotherapy
A groundbreaking Phase 2 clinical trial.
Neuroscientists Map the Brain’s Speech & Language Pathways
A groundbreaking study has revealed how.
Can Social Media Abstinence Improve Well-Being? Not Really
A new systematic review and meta-analysis.
Weekend Effect: Higher Mortality for Friday Surgeries
A recent study published in JAMA.
Chronic Cocaine Use Increases Impulsivity, Study Finds
A recent study published in eNeuro.
Father’s Diet & BMI Don’t Affect Newborn’s Birth Weight
A recent study published in Nutrients.
Leave a Comment